CN111818812B - 皮肤状态改善用组合物 - Google Patents

皮肤状态改善用组合物 Download PDF

Info

Publication number
CN111818812B
CN111818812B CN201980017850.3A CN201980017850A CN111818812B CN 111818812 B CN111818812 B CN 111818812B CN 201980017850 A CN201980017850 A CN 201980017850A CN 111818812 B CN111818812 B CN 111818812B
Authority
CN
China
Prior art keywords
skin
lactococcus
present application
bacterium
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980017850.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN111818812A (zh
Inventor
辻亮平
七尾宗龙
藤井敏雄
小久保健
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Holdings Co Ltd
Original Assignee
Kirin Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Holdings Co Ltd filed Critical Kirin Holdings Co Ltd
Publication of CN111818812A publication Critical patent/CN111818812A/zh
Application granted granted Critical
Publication of CN111818812B publication Critical patent/CN111818812B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN201980017850.3A 2018-03-15 2019-03-15 皮肤状态改善用组合物 Active CN111818812B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018-048311 2018-03-15
JP2018048311A JP6846376B2 (ja) 2018-03-15 2018-03-15 皮膚状態改善用組成物
PCT/JP2019/010773 WO2019177139A1 (ja) 2018-03-15 2019-03-15 皮膚状態改善用組成物

Publications (2)

Publication Number Publication Date
CN111818812A CN111818812A (zh) 2020-10-23
CN111818812B true CN111818812B (zh) 2023-09-26

Family

ID=67906705

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980017850.3A Active CN111818812B (zh) 2018-03-15 2019-03-15 皮肤状态改善用组合物

Country Status (8)

Country Link
US (1) US11497778B2 (enExample)
EP (1) EP3766363A4 (enExample)
JP (1) JP6846376B2 (enExample)
CN (1) CN111818812B (enExample)
AU (1) AU2019233471B2 (enExample)
NZ (1) NZ768504A (enExample)
SG (1) SG11202008959RA (enExample)
WO (1) WO2019177139A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3036937C (en) * 2016-09-15 2023-01-17 Kirin Company, Limited Composition which contains lactic acid bacterium as effective component and which is for preventing or ameliorating skin condition deterioration caused by abnormal proliferation of specific bacterium in skin
KR102754494B1 (ko) * 2020-10-30 2025-01-14 중앙대학교 산학협력단 락토코커스 중앙젠시스를 포함하는 피부 손상 예방 또는 치료용 조성물
JP2022145446A (ja) * 2021-03-19 2022-10-04 キリンホールディングス株式会社 紙臭が抑制された容器詰茶飲料、及びその製造方法
JP7248250B2 (ja) * 2021-04-28 2023-03-29 キリンホールディングス株式会社 乳酸球菌の増殖促進剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009066537A1 (ja) * 2007-11-19 2009-05-28 Meiji Dairies Corporation 免疫調節性機能誘導剤及び食品組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3715640B1 (ja) 2004-09-01 2005-11-09 フジッコ株式会社 ストレス由来の皮膚血流低下改善用組成物、皮膚機能改善用組成物およびそれらを用いた飲食品
CA2761573A1 (en) * 2009-05-11 2010-11-18 Nestec S.A. Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
US9439933B2 (en) 2010-06-28 2016-09-13 Kabushiki Kaisha Yakult Honsha Skin properties improving agent for oral administration
BR112013016690A2 (pt) * 2010-12-28 2016-10-04 Kirin Holdings Kk agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante
JP2013233097A (ja) * 2012-05-07 2013-11-21 Koiwai Nyugyo Kk 風味良好なドリンクタイプヨーグルト
KR101693574B1 (ko) 2014-09-23 2017-01-06 한국 한의학 연구원 틴달화 유산균 사균체를 유효성분으로 포함하는 피부 보습 또는 주름개선용 조성물
JP6713751B2 (ja) * 2015-10-26 2020-06-24 キリンホールディングス株式会社 抗原に対する特異的な細胞傷害性ｔ細胞（ｃｔｌ）及び抗体産生を増強させる方法
CA3036937C (en) 2016-09-15 2023-01-17 Kirin Company, Limited Composition which contains lactic acid bacterium as effective component and which is for preventing or ameliorating skin condition deterioration caused by abnormal proliferation of specific bacterium in skin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009066537A1 (ja) * 2007-11-19 2009-05-28 Meiji Dairies Corporation 免疫調節性機能誘導剤及び食品組成物

Also Published As

Publication number Publication date
JP2019156793A (ja) 2019-09-19
EP3766363A4 (en) 2022-01-05
AU2019233471B2 (en) 2024-03-28
US11497778B2 (en) 2022-11-15
US20210008127A1 (en) 2021-01-14
EP3766363A1 (en) 2021-01-20
WO2019177139A1 (ja) 2019-09-19
JP6846376B2 (ja) 2021-03-24
CN111818812A (zh) 2020-10-23
AU2019233471A1 (en) 2020-10-22
NZ768504A (en) 2025-08-29
SG11202008959RA (en) 2020-10-29

Similar Documents

Publication Publication Date Title
JP5791009B2 (ja) 乳酸菌およびそれらを用いた飲食物又は化粧品
KR101693574B1 (ko) 틴달화 유산균 사균체를 유효성분으로 포함하는 피부 보습 또는 주름개선용 조성물
CN111818812B (zh) 皮肤状态改善用组合物
JP5954828B2 (ja) 皮膚状態の改善用組成物
US12016890B2 (en) Composition for preventing or treating menopause, containing Lactobacillus intestinalis
CN108367033A (zh) 使用长双歧杆菌治疗或预防抑郁症状的方法和组合物
KR20140128675A (ko) 피부 주름 개선 및 보습 효능을 갖는 신규의 락토바실러스 가세리 ｈｙ７０２５ 유산균 및 이를 유효성분으로 함유하는 제품
KR102122652B1 (ko) 락토바실러스 루테리 제제를 이용한 피부개선용 조성물
JP7379152B2 (ja) 筋線維化抑制用組成物
US20250032401A1 (en) Composition for improving skin condition
JP7041508B2 (ja) 概日リズム改善用組成物
JP2008088123A (ja) 美肌用組成物
KR102429565B1 (ko) 락토바실러스 플란타럼 큐원을 유효성분으로 함유하는 탈모 예방 또는 치료용 조성물
US7951844B2 (en) Tranquilizer and functional food
JP6482930B2 (ja) 皮膚化粧料および飲食品
AU2016230139A1 (en) Fermented tea product
KR101742542B1 (ko) 틴달화 유산균 사균체를 유효성분으로 포함하는 피부 보습 또는 주름개선용 조성물
TW201620530A (zh) 鎮靜用之自律神經調節劑及晝夜節律改善劑
CN100534446C (zh) 护肤用口服组合物
JP2023541269A (ja) 座瘡の治療のためのプロバイオティクス組成物
JP2008074816A (ja) 生体内抗酸化剤
US11103543B2 (en) Composition for recovering from fatigue and/or preventing fatigue accumulation
KR102218992B1 (ko) 아가토바쿨룸 속 균주를 유효성분으로 함유하는 자폐 범주성 장애의 예방, 개선 또는 치료용 조성물
CN104812253B (zh) 用具有低血糖指数的碳水化合物增加黄烷-3-醇的生物利用度
HK40042697A (en) Composition for improving skin conditions

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant